rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jennifer Grancio

Director

Company insider

Files Form 4 as: Director, MannKind.

In numbers

Trades disclosed
10
Buys
1
Sells
0
Bought
$300K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
23 Mar 2020
Last trade
20 May 2026
Last filed
22 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MNKD MannKindDirector · Pharmaceuticals · last 20 May 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 May 2026filed 22 May 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—82,781 at $0.00filing
20 May 2026filed 22 May 2026MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—82,781 at $0.00filing
14 May 2025filed 16 May 2025MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—52,854 at $0.00filing
15 May 2024filed 17 May 2024MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—35,047 at $0.00filing
25 May 2023filed 26 May 2023MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—35,545 at $0.00filing
10 May 2022filed 12 May 2022MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—45,045 at $0.00filing
28 Feb 2022filed 1 Mar 2022MNKD MannKindPharmaceuticalsSEC FORM 4 Bought$300K110,701 at $2.71filing
20 May 2021filed 20 May 2021MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—33,860 at $0.00filing
21 May 2020filed 26 May 2020MNKD MannKindoption or derivative · PharmaceuticalsSEC FORM 4 Code A—88,235 at $0.00filing
23 Mar 2020filed 26 Mar 2020MNKD MannKindPharmaceuticalsSEC FORM 4 Code A—12,019 at $0.00filing

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Steven B. BinderDirector · Director at Mannkind, filing Form 4 there in the last year
Christopher B. PrentissChief Financial Officer · Chief Financial Officer at Mannkind, filing Form 4 there in the last year
Michael CastagnaChief Executive Officer · Chief Executive Officer at Mannkind, filing Form 4 there in the last year
Sanjay R. SinghEVP Technical Operations · EVP Technical Operations at Mannkind, filing Form 4 there in the last year
Dominic MarascoPres, Endocrine Business Unit · Pres, Endocrine Business Unit at Mannkind, filing Form 4 there in the last year